Fieldpoint Private Securities’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$65K Buy
139
+89
+178% +$39.6K 0.02% 434
2022
Q1
$22K Sell
50
-18
-26% -$7.53K ﹤0.01% 823
2021
Q4
$32K Sell
68
-13
-16% -$5.75K 0.01% 731
2021
Q3
$32K Buy
81
+13
+19% +$5.52K 0.01% 684
2021
Q2
$28K Hold
68
0.01% 710
2021
Q1
$29K Sell
68
-844
-93% -$337K 0.01% 698
2020
Q4
$374K Buy
912
+88
+11% +$36.6K 0.09% 225
2020
Q3
$341K Buy
824
+163
+25% +$65.6K 0.1% 206
2020
Q2
$256K Buy
+661
New +$247K 0.09% 207
2019
Q3
Sell
-255
Closed -$68K 710
2019
Q2
$68K Sell
255
-218
-46% -$55.3K 0.02% 388
2019
Q1
$126K Hold
473
0.05% 227
2018
Q4
$136K Hold
473
0.06% 219
2018
Q3
$160K Hold
473
0.06% 225
2018
Q2
$141K Hold
473
0.05% 232
2018
Q1
$127K Hold
473
0.06% 211
2017
Q4
$117K Hold
473
0.06% 216
2017
Q3
$115K Buy
+473
New +$116K 0.05% 254
2017
Q2
Sell
-218
Closed -$45K 230
2017
Q1
$45K Buy
+218
New +$45.1K 0.03% 203

Other funds holding HUM

Fieldpoint Private Securities's HUM Position: Q2 2022 in Review

Fieldpoint Private Securities increased its Humana (HUM) stake by 178% in Q2 2022, buying an estimated $39.6K and bringing the position to 139 shares worth $65K. The position accounts for 0.02% of the portfolio, ranked #434.

Fieldpoint Private Securities first reported a position in HUM in Q1 2017 and has held it in 18 quarters since. The position peaked at $374K in Q4 2020. 959 funds tracked by Wall St. Rank hold HUM as of Q2 2022.

  • Fieldpoint Private Securities held 139 shares of Humana worth $65K as of Q2 2022.
  • Fieldpoint Private Securities bought 89 Humana shares in Q2 2022, an estimated $39.6K.
  • Humana made up 0.02% of Fieldpoint Private Securities's portfolio in Q2 2022, its #434 holding.
  • Fieldpoint Private Securities first reported a position in Humana in Q1 2017 and has held it in 18 quarters since.
  • Fieldpoint Private Securities's Humana position peaked at $374K in Q4 2020.
  • 959 funds tracked by Wall St. Rank held Humana as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.